Lannett Co Inc financial data

Industry
Pharmaceutical Preparations
Location
9000 State Rd, Philadelphia, PA
State of incorporation
DE
Fiscal year end
June 30

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 101 % -71.7%
Quick Ratio 35.4 % -67.7%
Debt-to-equity -238 % +70.5%
Return On Equity 82.7 %
Return On Assets -60.1 %
Operating Margin -61.9 % -89.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.8M shares -74.9%
Common Stock, Shares, Outstanding 10.8M shares -73.5%
Common Stock, Value, Issued 11K USD -73.8%
Weighted Average Number of Shares Outstanding, Basic 10.3M shares +1.83%
Weighted Average Number of Shares Outstanding, Diluted 10.3M shares +1.83%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 311M USD -16.6%
Research and Development Expense 25.3M USD +13.1%
Operating Income (Loss) -192M USD -58%
Nonoperating Income (Expense) -66.1M USD +2.82%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -259M USD -36.2%
Income Tax Expense (Benefit) 582K USD -99.5%
Net Income (Loss) Attributable to Parent -259M USD -191%
Earnings Per Share, Basic -11.1 USD/shares -5.5%
Earnings Per Share, Diluted -11.1 USD/shares -5.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.5M USD -56.1%
Accounts Receivable, after Allowance for Credit Loss, Current 68.2M USD +6.53%
Inventory, Net 90.8M USD -4.85%
Other Assets, Current 18M USD +12.9%
Assets, Current 262M USD -17.9%
Property, Plant and Equipment, Net 12.4M USD -91.2%
Operating Lease, Right-of-Use Asset 9.13M USD -8.95%
Intangible Assets, Net (Excluding Goodwill) 18.9M USD -78.6%
Other Assets, Noncurrent 14.5M USD -3.82%
Assets 335M USD -41.5%
Accounts Payable, Current 21.1M USD -26.2%
Employee-related Liabilities, Current 11.9M USD +10.2%
Accrued Liabilities, Current 34.9M USD +120%
Liabilities, Current 733M USD +677%
Operating Lease, Liability, Noncurrent 9.16M USD -11%
Other Liabilities, Noncurrent 4.65M USD -72.5%
Liabilities 747M USD +2.09%
Accumulated Other Comprehensive Income (Loss), Net of Tax -384K USD +27%
Retained Earnings (Accumulated Deficit) -762M USD -51.5%
Stockholders' Equity Attributable to Parent -412M USD -159%
Liabilities and Equity 335M USD -41.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.3M USD -166%
Net Cash Provided by (Used in) Financing Activities -68K USD +88.3%
Net Cash Provided by (Used in) Investing Activities 1.43M USD
Common Stock, Shares Authorized 25M shares -75%
Common Stock, Shares, Issued 11.2M shares -73.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.94M USD -183%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.5M USD -53.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.82M USD +2720%
Deferred Tax Assets, Valuation Allowance 193M USD +26.1%
Deferred Tax Assets, Gross 213M USD +27.1%
Operating Lease, Liability 11.2M USD -8.97%
Depreciation 20.7M USD -5.48%
Payments to Acquire Property, Plant, and Equipment 2.77M USD -20.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -259M USD -191%
Lessee, Operating Lease, Liability, to be Paid 15.4M USD -11.8%
Operating Lease, Liability, Current 2.08M USD +0.97%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.1M USD +0.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.08M USD +0.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.12M USD -18.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.12M USD +1%
Unrecognized Tax Benefits 4.6M USD +2.22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.15M USD +0.99%
Operating Lease, Payments 673K USD +13.5%
Amortization of Intangible Assets 6.1M USD -56.7%
Depreciation, Depletion and Amortization 6.21M USD -35.2%
Deferred Tax Assets, Net of Valuation Allowance 19.2M USD +37.1%
Share-based Payment Arrangement, Expense 5.97M USD -32.7%
Interest Expense 60.2M USD +6.76%